0001415889-23-003569.txt : 20230228
0001415889-23-003569.hdr.sgml : 20230228
20230228201732
ACCESSION NUMBER: 0001415889-23-003569
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230226
FILED AS OF DATE: 20230228
DATE AS OF CHANGE: 20230228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRAY SUSANNAH
CENTRAL INDEX KEY: 0001833453
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36033
FILM NUMBER: 23689009
MAIL ADDRESS:
STREET 1: 10770 WATERIDGE CIRCLE SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Theravance Biopharma, Inc.
CENTRAL INDEX KEY: 0001583107
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET
CITY: GEORGE TOWN, GRAND CAYMAN
STATE: E9
ZIP: KY1-1104
BUSINESS PHONE: 650-808-6000
MAIL ADDRESS:
STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET
CITY: GEORGE TOWN, GRAND CAYMAN
STATE: E9
ZIP: KY1-1104
4
1
form4-03012023_010311.xml
X0306
4
2023-02-26
0001583107
Theravance Biopharma, Inc.
TBPH
0001833453
GRAY SUSANNAH
C/O THERAVANCE BIOPHARMA US, INC.
SOUTH SAN FRANCISCO
CA
94080
true
false
false
false
Ordinary Shares
2023-02-26
4
A
0
10131
0
A
10131
D
Ordinary Shares
2023-02-26
4
A
0
1688
0
A
11819
D
Share Option (Right to Buy)
9.87
2023-02-26
4
A
0
28000
0
A
2033-02-25
Ordinary Shares
28000
28000
D
Share Option (Right to Buy)
9.87
2023-02-26
4
A
0
4666
0
A
2033-02-25
Ordinary Shares
4666
4666
D
The option vests monthly over 24 months of service from the date of grant.
This option shall vest monthly over two months of service from the date of grant and will vest in full upon earlier of the two-month anniversary of Susannah Gray's appointment to the Board or the date of Company's 2023 annual meeting of Shareholders.
/s/ Brett A. Grimaud, Attorney-in-Fact
2023-02-28